Inactive Instrument
ENTST BIO Stock Other OTC
Stocks
Investment Holding Companies
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 21/01/20 | Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019 | CI |
| 20/12/19 | Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019 | CI |
| Market Cap | 541K 470K 438K 402K 759K 51.63M 771K 5.16M 2.02M 25.71M 2.03M 1.99M 86.19M | P/E 2018 |
-0.92x | P/E 2019 | 12.6x |
|---|---|---|---|---|---|
| Enterprise Value | 562K 489K 455K 418K 789K 53.66M 801K 5.36M 2.1M 26.71M 2.11M 2.06M 89.57M | EV / Sales 2018 |
-
| EV / Sales 2019 | - |
| Free-Float |
98.54% | Yield 2018 * |
-
| Yield 2019 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.93% | -6.72% | -53.83% | - | 13.74B | |
| +11.61% | -0.80% | +5.49% | - | 1.26B | |
| -1.00% | +1.32% | - | - | 772M | |
| -0.10% | +0.10% | - | - | 644M | |
| -.--% | -6.95% | +268.42% | -68.57% | 621M | |
| +0.24% | -2.30% | - | - | 607M | |
| -.--% | -0.05% | - | - | 597M | |
| -.--% | -0.86% | - | - | 595M | |
| Average | +1.10% | +0.68% | +73.36% | -68.57% | 2.35B | |
| Weighted average by Cap. | -0.67% | +11.44% | -36.23% | -68.57% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.48M -1.28M -1.2M -1.1M -2.07M -141M -2.1M -14.09M -5.53M -70.22M -5.55M -5.43M -235M | 192K 167K 155K 142K 269K 18.29M 273K 1.83M 717K 9.11M 720K 704K 30.54M |
| Net Debt | 19.4K 16.86K 15.7K 14.41K 27.22K 1.85M 27.64K 185K 72.62K 922K 72.86K 71.26K 3.09M | 21.2K 18.43K 17.15K 15.75K 29.74K 2.02M 30.2K 202K 79.34K 1.01M 79.61K 77.86K 3.38M |
Employees
-
Sector
Investment Holding Companies
Select your edition
All financial news and data tailored to specific country editions
